PubRank

Armando Sardi

Author PubWeight™ 20.79‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol 2012 5.06
2 Improved results using ultrasound guidance for central venous access. Am Surg 2003 1.15
3 The role of cytoreductive surgery and heated intraperitoneal chemotherapy (CRS/HIPEC) in patients with high-grade appendiceal carcinoma and extensive peritoneal carcinomatosis. Ann Surg Oncol 2011 1.00
4 Prognostic significance of lymph node metastases in patients with high-grade appendiceal cancer. Ann Surg Oncol 2011 1.00
5 The American Society of Peritoneal Surface Malignancies evaluation of HIPEC with Mitomycin C versus Oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgery. J Surg Oncol 2014 1.00
6 Racial differences in mammographic breast density. Cancer 2003 0.98
7 Pseudomyxoma peritonei: is disease progression related to microbial agents? A study of bacteria, MUC2 AND MUC5AC expression in disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. Ann Surg Oncol 2008 0.97
8 Absence of the retrohepatic inferior vena cava: what the surgeon should know. Am Surg 2005 0.93
9 Antibiotic treatment decreases microbial burden associated with pseudomyxoma peritonei and affects β-catenin distribution. Clin Cancer Res 2013 0.93
10 The American Society of Peritoneal Surface Malignancies (ASPSM) Multiinstitution Evaluation of the Peritoneal Surface Disease Severity Score (PSDSS) in 1,013 Patients with Colorectal Cancer with Peritoneal Carcinomatosis. Ann Surg Oncol 2014 0.93
11 A core microbiome associated with the peritoneal tumors of pseudomyxoma peritonei. Orphanet J Rare Dis 2013 0.90
12 Neoplasms of the appendix: current treatment guidelines. Hematol Oncol Clin North Am 2012 0.90
13 Complete cytoreduction offers longterm survival in patients with peritoneal carcinomatosis from appendiceal tumors of unfavorable histology. J Am Coll Surg 2009 0.82
14 A case report of recurrent epithelial ovarian cancer metastatic to the sternum, diaphragm, costae, and bowel managed by aggressive secondary cytoreductive surgery without postoperative chemotherapy. Gynecol Oncol 2002 0.82
15 Predictive and prognostic survival factors in peritoneal carcinomatosis from appendiceal cancer after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 2014 0.81
16 Port-site metastases is an independent prognostic factor in patients with peritoneal carcinomatosis. Ann Surg Oncol 2014 0.80
17 Morbidity of the abdominal wall resection and reconstruction after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC). Ann Surg Oncol 2014 0.77
18 Technetium-99m sestamibi scintimammography complements mammography in the detection of breast cancer. Breast J 2003 0.77
19 Hemicorporectomy for chronic pressure ulcer carcinoma: 7 years of follow-up. Am Surg 2004 0.76
20 Thoracoscopic resection of a mediastinal intrathymic parathyroid adenoma. Am Surg 2005 0.76
21 Delay of cytoreductive surgery and heated intraperitoneal chemotherapy in patients with appendiceal neoplasm. Am Surg 2012 0.75
22 Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Mesothelioma: Experience of a Peritoneal Surface Malignancy Center. Am Surg 2015 0.75
23 Results of curative therapy for esophageal cancer in a community training hospital. Int Surg 2002 0.75